European Consortium Launches 10-year, $1.2B Diabetes Project | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative for Diabetes on Monday announced a €1 billion ($1.2 billion), 10-year project focusing on pancreatic islet cell function and survival.

The project will involve research into developing biomarkers and tools to better manage diabetes with the hope of curing the disease, which affects 285 million people worldwide, IMIDIA said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.